of the ovary is both the most prevalent and lethal form of gynaecological
carcinoma. In Australia it is the eighth most common cancer among the
general population of women. At present there is no effective technique
of routine population screening for ovarian cancer and ovarian tumours
typically present at an advanced stage, where the survival rate is less
than 20%. In comparison, the survival rate for early stage cancer is
90% or better. Early diagnosis however is difficult as symptoms are
often vague and resemble other common medical conditions.
AOCS has recently announced a research partnership with Ovarian Cancer Australia (OCA), the national not-for-profit organisation that provides support and advocacy for people with ovarian cancer and the peak body for ovarian cancer awareness and prevention. We are excited about this partnership and hope that together we can raise awareness and foster research into ovarian cancer in Australia.
For more information about Ovarian Cancer Australia, go to http://www.ovariancancer.net.au